Gastrinoma Diagnosis and Clinical Presentation

Introduction to Gastrinoma

Gastrinoma typically presents with severe gastroduodenal ulcer symptoms, such as dyspepsia or indigestion, usually accompanied by diarrhea, which aligns with the indigestion mentioned in this case 1, 2
Hypercalcemia in this context strongly suggests MEN1 syndrome, where hyperparathyroidism is the most common manifestation and frequently coexists with gastrinoma 1, 2
Approximately 70% of MEN1 patients with gastrinoma have tumors in the duodenum 1, 2

Insulinomas present with neuroglycopenic symptoms, such as confusion, lethargy, seizures, and hypoglycemia, NOT with elevated gastrin levels or indigestion 3
The diagnostic criteria for insulinoma require demonstrating inappropriate insulin secretion during documented hypoglycemia 1, 3
There is no pathophysiologic connection between insulinoma and elevated gastrin levels or hypercalcemia 1, 2

A fasting serum gastrin level >10 times elevated AND gastric pH <2 is diagnostic of gastrinoma 1, 4
Gastrin levels must be measured after stopping proton pump inhibitors for at least 1 week, as PPIs spuriously elevate gastrin levels 1, 2, 4
Most patients with elevated gastrin do NOT have gastrinoma but rather have achlorhydria or are taking PPIs/antacids 1, 2

The combination of hypercalcemia with gastrinoma is pathognomonic for MEN1 syndrome 1, 2
Gastrinoma and insulinoma are the two most common pancreatic islet cell tumors in MEN1, but they present with completely different symptom profiles 2